Terms: = Liver cancer AND CNBP, P62633, 7555, ENSG00000169714, ZNF9, RNF163, DM2
22 results:
1. Interplay of Ritonavir-Boosted Oral Cabazitaxel with the Organic Anion-Transporting Polypeptide (OATP) Uptake Transporters and Carboxylesterase 1 in Mice.
Loos NHC; Ferreira Martins ML; Rijmers J; de Jong D; Lebre MC; Tibben M; Beijnen JH; Schinkel AH
Mol Pharm; 2024 Apr; 21(4):1952-1964. PubMed ID: 38423793
[TBL] [Abstract] [Full Text] [Related]
2. Hepatocellular carcinoma, multiple primary neoplasia, and their association with diabetes type 2.
Žabová L; Hříbek P; Klasová J; Příhodová K; Urbánek P
Cas Lek Cesk; 2023; 162(2-3):112-118. PubMed ID: 37474296
[TBL] [Abstract] [Full Text] [Related]
3. Hepatocellular carcinoma in a large cohort of type 2 diabetes patients.
Giorda CB; Picariello R; Tartaglino B; Nada E; Costa G; Manti R; Monge L; Gnavi R
Diabetes Res Clin Pract; 2023 Jun; 200():110684. PubMed ID: 37100229
[TBL] [Abstract] [Full Text] [Related]
4. [Malnutrition management of hospitalized patients with diabetes/hyperglycemia and liver cirrhosis].
Matía Martín P; González-Sánchez V; Burgos Peláez R; García Almeida JM; Palma Milla S; Sanz Paris A; Zugasti Murillo A; Alfaro Martínez JJ; Artero-Fullana A; Calañas Continente A; Chinchetru MªJ; García Malpartida K; González-Díaz Faes Á; Laínez López M; Serrano-Moreno C; Martínez-Ortega AJ; Suárez Llanos JP; Oliva Roldán J
Nutr Hosp; 2022 Dec; 39(Spec No4):47-54. PubMed ID: 36546332
[TBL] [Abstract] [Full Text] [Related]
5. Influence of antidiabetic drugs on glucose metabolism and immune response in patients with metastatic pancreatic ductal adenocarcinoma receiving gemcitabine plus nab-paclitaxel as first-line treatment.
Pretta A; Ziranu P; Giampieri R; Donisi C; Cimbro E; Spanu D; Lai E; Pecci F; Balconi F; Lupi A; Pozzari M; Persano M; Murgia S; Pusceddu V; Puzzoni M; Berardi R; Scartozzi M
Dig Liver Dis; 2023 May; 55(5):655-660. PubMed ID: 36513569
[TBL] [Abstract] [Full Text] [Related]
6. Metformin prevents liver tumourigenesis by attenuating fibrosis in a transgenic mouse model of hepatocellular carcinoma.
Shankaraiah RC; Callegari E; Guerriero P; Rimessi A; Pinton P; Gramantieri L; Silini EM; Sabbioni S; Negrini M
Oncogene; 2019 Nov; 38(45):7035-7045. PubMed ID: 31409896
[TBL] [Abstract] [Full Text] [Related]
7. Phosphoglucomutase 1 inhibits hepatocellular carcinoma progression by regulating glucose trafficking.
Jin GZ; Zhang Y; Cong WM; Wu X; Wang X; Wu S; Wang S; Zhou W; Yuan S; Gao H; Yu G; Yang W
PLoS Biol; 2018 Oct; 16(10):e2006483. PubMed ID: 30335765
[TBL] [Abstract] [Full Text] [Related]
8. Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale.
Casadei Gardini A; Faloppi L; De Matteis S; Foschi FG; Silvestris N; Tovoli F; Palmieri V; Marisi G; Brunetti O; Vespasiani-Gentilucci U; Perrone G; Valgiusti M; Granato AM; Ercolani G; Negrini G; Tamburini E; Aprile G; Passardi A; Santini D; Cascinu S; Frassineti GL; Scartozzi M
Eur J Cancer; 2017 Nov; 86():106-114. PubMed ID: 28985579
[TBL] [Abstract] [Full Text] [Related]
9. Metformin Has Positive Therapeutic Effects in Colon cancer and Lung cancer.
Henderson D; Frieson D; Zuber J; Solomon SS
Am J Med Sci; 2017 Sep; 354(3):246-251. PubMed ID: 28918830
[TBL] [Abstract] [Full Text] [Related]
10. Impact of sustained virological response to chronic hepatitic C antiviral therapy on new onset diabetes mellitus type 2 after controlling for metabolic syndrome.
Pandya P; Pant C; Taylor R; Oni O
J Investig Med; 2017 Apr; 65(4):765-771. PubMed ID: 28232517
[TBL] [Abstract] [Full Text] [Related]
11. Abnormal splicing of NEDD4 in myotonic dystrophy type 2: possible link to statin adverse reactions.
Screen M; Jonson PH; Raheem O; Palmio J; Laaksonen R; Lehtimäki T; Sirito M; Krahe R; Hackman P; Udd B
Am J Pathol; 2014 Aug; 184(8):2322-32. PubMed ID: 24907641
[TBL] [Abstract] [Full Text] [Related]
12. cancer detection rates following enrolment in a disease management programme for type 2 diabetes.
Geier AS; Wellmann J; Wellmann I; Kajüter H; Heidinger O; Hempel G; Hense HW
Diabetologia; 2013 Sep; 56(9):1944-8. PubMed ID: 23722623
[TBL] [Abstract] [Full Text] [Related]
13. Preoperative glucose and protein metabolism: the influence of diabetes mellitus type 2 in patients with colorectal tumors.
Lugli AK; Donatelli F; Schricker T; Wykes L; Carli F
Nutr Cancer; 2011; 63(6):924-9. PubMed ID: 21745052
[TBL] [Abstract] [Full Text] [Related]
14. Alcohol and HCV chronic infection are risk cofactors of type 2 diabetes mellitus for hepatocellular carcinoma in Italy.
Balbi M; Donadon V; Ghersetti M; Grazioli S; Valentina GD; Gardenal R; Mas MD; Casarin P; Zanette G; Miranda C; Cimarosti P
Int J Environ Res Public Health; 2010 Apr; 7(4):1366-78. PubMed ID: 20617035
[TBL] [Abstract] [Full Text] [Related]
15. Glycated hemoglobin and antidiabetic strategies as risk factors for hepatocellular carcinoma.
Donadon V; Balbi M; Valent F; Avogaro A
World J Gastroenterol; 2010 Jun; 16(24):3025-32. PubMed ID: 20572306
[TBL] [Abstract] [Full Text] [Related]
16. Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease.
Donadon V; Balbi M; Mas MD; Casarin P; Zanette G
Liver Int; 2010 May; 30(5):750-8. PubMed ID: 20331505
[TBL] [Abstract] [Full Text] [Related]
17. Association between hepatocellular carcinoma and type 2 diabetes mellitus in Italy: potential role of insulin.
Donadon V; Balbi M; Casarin P; Vario A; Alberti A
World J Gastroenterol; 2008 Oct; 14(37):5695-700. PubMed ID: 18837086
[TBL] [Abstract] [Full Text] [Related]
18. [Insulin resistance/hyperinsulinemia associated diseases not included in the metabolic syndrome].
Carvalheira JB; Saad MJ
Arq Bras Endocrinol Metabol; 2006 Apr; 50(2):360-7. PubMed ID: 16767302
[TBL] [Abstract] [Full Text] [Related]
19. Low-dose oral glyburide reduces glucose production rates in patients with impaired fasting glucose.
Bavirti S; Tayek JA
Metabolism; 2003 Apr; 52(4):407-12. PubMed ID: 12701050
[TBL] [Abstract] [Full Text] [Related]
20. Characterization of novel human hepatoma cell lines with stable hepatitis B virus secretion for evaluating new compounds against lamivudine- and penciclovir-resistant virus.
Fu L; Cheng YC
Antimicrob Agents Chemother; 2000 Dec; 44(12):3402-7. PubMed ID: 11083647
[TBL] [Abstract] [Full Text] [Related]
[Next]
